Startup Professionals Musings
OCTOBER 27, 2014
I always advise software startups to file patents to protect their “secret sauce” from competitors, and to increase their valuation. The good news is that a patent can scare off or at least delay competitors, and as a “rule of thumb” patents can add up to $1M to your startup valuation for investors or M&A exits (merger and acquisition).
Startup Professionals Musings
DECEMBER 13, 2012
I always advise software startups to file patents to protect their “secret sauce” from competitors, and to increase their valuation. This patent holding company has charged infringement and demanded royalties from every app developer for the iPhone and Android, for a feature most agree has been in apps for many years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Startup Professionals Musings
JULY 7, 2011
I always advise software startups to file patents to protect their “secret sauce” from competitors, and to increase their valuation. The bad news is that patent trolls can squeeze the lifeblood out of innocent and unsuspecting entrepreneurs, as exemplified by the current mess around Lodsys patent No.
Startup Professionals Musings
MAY 29, 2010
I always advise software startups to file patents to protect their “secret sauce” from competitors, and to increase their valuation. Yet the software patent process is a mess. I say this with conviction even after I survived the process, and have a software patent pending. Patents granted that don’t meet the criteria.
TechCrunch LA
MARCH 22, 2018
As BCG writes in its report: The good news for SoCal and any region with tech ambitions is that the Bay Area has in some ways been too successful. Caltech generates more patents than any other university while UCLA boasts more startups founded by its graduate than any other school in the nation.
Xconomy
JUNE 3, 2016
But billions of dollars in acquisitions will be left by the side of the road. Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin).
socalTECH
JUNE 19, 2009
Thanks to all of the sponsors and advertisers, who allow us to keep you updated on Southern California's high tech news and companies. and international patent and trademark procurement - IP. Litigation - IP Licenses and Agreements: distribution, development, joint venture - Intellectual property aspects of mergers and acquisitions.
Expert insights. Personalized for you.
100 
Let's personalize your content